Large-Scale Population Analysis Challenges the Current Criteria for the Molecular Diagnosis of Fascioscapulohumeral Muscular Dystrophy


Autoria(s): Scionti, Isabella; Greco, Francesca; Ricci, Giulia; Govi, Monica; Arashiro, Patricia; Vercelli, Liliana; Berardinelli, Angela; Angelini, Corrado; Antonini, Giovanni; Cao, Michelangelo; Di Muzio, Antonio; Moggio, Maurizio; Morandi, Lucia; Ricci, Enzo; Rodolico, Carmelo; Ruggiero, Lucia; Santoro, Lucio; Siciliano, Gabriele; Tomelleri, Giuliano; Trevisan, Carlo Pietro; Galluzzi, Giuliana; Wright, Woodring; Zatz, Mayana; Tupler, Rossella
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

14/10/2013

14/10/2013

2012

Resumo

Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary myopathy causally linked to reduced numbers (<= 8) of 3.3 kilobase D4Z4 tandem repeats at 4q35. However, because individuals carrying D4Z4-reduced alleles and no FSHD and patients with FSHD and no short allele have been observed, additional markers have been proposed to support an FSHD molecular diagnosis. In particular a reduction in the number of D4Z4 elements combined with the 4A(159/161/168)PAS haplotype (which provides the possibility of expressing DUX4) is currently used as the genetic signature uniquely associated with FSHD. Here, we analyzed these DNA elements in more than 800 Italian and Brazilian samples of normal individuals unrelated to any FSHD patients. We find that 3% of healthy subjects carry alleles with a reduced number (4-8) of D4Z4 repeats on chromosome 4q and that one-third of these alleles, 1.3%, occur in combination with the 4A161PAS haplotype. We also systematically characterized the 4q35 haplotype in 253 unrelated FSHD patients. We find that only 127 of them (50.1%) carry alleles with 1-8 D4Z4 repeats associated with 4A161PAS, whereas the remaining FSHD probands carry different haplotypes or alleles with a greater number of D4Z4 repeats. The present study shows that the current genetic signature of FSHD is a common polymorphism and that only half of FSHD probands carry this molecular signature. Our results suggest that the genetic basis of FSHD, which is remarkably heterogeneous, should be revisited, because this has important implications for genetic counseling and prenatal diagnosis of at-risk families.

Telethon [GUP08004, GUP11009]

Telethon

Association Francaise Contre les Myopathies

Association Francaise Contre les Myopathies [14339]

National Institute of Health-National Institutes of Neurological Disorders and Stroke [RO1 NS047584]

National Institute of HealthNational Institutes of Neurological Disorders and Stroke

Centros de Pesquisa, Inovacao e Difusao/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Centros de Pesquisa, Inovacao e Difusao/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Institutos Nacionais de Ciencia e Tecnologia

Institutos Nacionais de Ciencia e Tecnologia

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Identificador

AMERICAN JOURNAL OF HUMAN GENETICS, CAMBRIDGE, v. 90, n. 4, supl. 1, Part 3, pp. 628-635, APR 6, 2012

0002-9297

http://www.producao.usp.br/handle/BDPI/34535

10.1016/j.ajhg.2012.02.019

http://dx.doi.org/10.1016/j.ajhg.2012.02.019

Idioma(s)

eng

Publicador

CELL PRESS

CAMBRIDGE

Relação

AMERICAN JOURNAL OF HUMAN GENETICS

Direitos

restrictedAccess

Copyright CELL PRESS

Palavras-Chave #DNA REARRANGEMENTS #4Q35 DELETION #FSHD #PHENOTYPE #LOCUS #D4Z4 #CHROMOSOME-4 #D4F104S1 #FRAGMENT #FAMILY #GENETICS & HEREDITY
Tipo

article

original article

publishedVersion